Medical device recalls Moderate risk

BioMerieux SA recalls API ZYM Bx2 (Ref 70493) Product Usage: ZYM B reagent is an additional test used for revealing the results of some minia…

Recall date
January 8, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0756-2016
FDA classification
Class II
Brand / firm
BioMerieux SA
Sold / distributed
Nationwide Distribution in the states of: AL, CA, CO, CT, DC, FL, GA, HI, IL, IN, IA, KS, KY, ME, MD, MA, MI, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TX, VT, VA, WA, WV, WI, WY

Why it was recalled

Discrepant identification results related to API identification strips. These discrepant identification results are due to false negative results on the tests of the strips linked to the ZYM B reagent.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

API ZYM Bx2 (Ref 70493) Product Usage: ZYM B reagent is an additional test used for revealing the results of some miniaturized biochemical test including in the involved API strips.

Get recall alerts

Free email alert whenever BioMerieux SA has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: BioMerieux SA